Last updated on October 2016

This clinical study will measure the effectiveness of a new adjunctive treatment for people with type 1 diabetes.


Brief description of study

This clinical study will measure the effectiveness of a new adjunctive treatment for people with type 1 diabetes.

Detailed Study Description

The purpose of this study is to evaluate the effectiveness of empagliflozin as a complimentary treatment to people with type 1 diabetes.

Clinical Study Identifier: TX145867

Find a site near you

Start Over

Pacific Research Partners

901 Clay St. Oakland, CA USA
  Connect »